SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cartography Biosciences, Inc., a clinical-stage biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that CEO and co-founder Kevin Parker, Ph.D., will participate in the following upcoming investor conferences: BofA Healthcare Trailblazers Private Company Conference: September 23-24 in Boston Needham Private Biotech and MedTech Company Virtual 1×1 Forum: October 13-14 Goldman Sachs Healthcare